FundedIQ
Biopharma

SiccaNova Therapeutics: Funding, Investors & Team (Oct 2026)

SiccaNova Therapeuticsis a startup developing novel low-molecular therapeutics targeting dry mouth (xerostomia) and dry eye conditions.

www.siccanova.com Tsukuba, Japan Founded 2022
Total raised
$7.9M
Rounds
1
Latest
Series A
Sep 2026

SiccaNova Therapeutics has raised $7.9M across 1 funding round on record, the most recent a Series A of $7.9M announced in Sep 2026.

That round is above the $3.3M median round size for Japan companies tracked on FundedIQ over the last two years.

SiccaNova Therapeutics Company Profile and Key Stats

Total funding raised
$7.9M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$7.9M in Sep 2026
Founded
2022
Headquarters
Tsukuba, Japan
Investors on record
6
5 named below

Latest funding round on record: Sep 2026.

SiccaNova Therapeutics Funding Rounds

Date
Round
Amount
Series A
$7.9M

SiccaNova Therapeutics Investors

JIC Venture Growth Investments MPower Partners Tohoku University Venture Partners Joyo Capital Partners 77 Partners

6 investors are recorded in total; the 5 named above are those the record identifies.

SiccaNova Therapeutics Funding in Context

Segment
Companies
Median round
369
$3.3M
8,591
$15M

SiccaNova Therapeutics' latest round of $7.9M is above the median round in Japan. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like SiccaNova Therapeutics in Biopharma and Tsukuba

Companies Similar to SiccaNova Therapeutics

Tikva Allocell is a biotechnology company that specializes in next-gen cell therapies.

Series A $8.0M

Wasimil is an IT services company that expertise in the development of an automated management system for…

Series A $3.1M

Mujin provides automation solutions for industrial robots to simplify factory and logistics automation and…

Series D $224M

esa is a Technology-Driven Solutions Company transforming hard-to-recycle composite plastics into valuable…

Undisclosed round $7.3M

Nessu is a food delivery app that seamlessly connects supermarkets to households and parents to help reduce…

Series A $570k

Flyle provides a cloud-based platform for product management to improve productivity and creativity in…

Series A $11.9M

Subliminal develops and operates an AI-driven Enterprise Resource Planning (ERP) platform named "unito".

Seed $250k

Celaid Therapeutics is a biotech company that develops cell therapies for blood cancer, intractable blood…

Series B $2.5M

JAOPS develops space mission operations software, tools, training, and services for spacecraft control and…

Seed $1.6M

WAKA is a studio that produces metaverse games and specializes in contract development for domestic…

Private Equity $1.6M

Mutex is a software engineering firm that designs, develops, maintains, and markets computer software and…

Series A $1.8M

Bridgesmile operates an on-site installation and replacement service platform.

Series A $51.9M

SiccaNova Therapeutics Funding FAQs

What does SiccaNova Therapeutics do?

SiccaNova Therapeuticsis a startup developing novel low-molecular therapeutics targeting dry mouth (xerostomia) and dry eye conditions.

How much funding has SiccaNova Therapeutics raised?

SiccaNova Therapeutics has raised $7.9M across 1 round on record. The most recent is a Series A of $7.9M announced in Sep 2026.

When did SiccaNova Therapeutics last raise funding?

SiccaNova Therapeutics' most recent funding round on record is a Series A of $7.9M, announced in Sep 2026.

Who has invested in SiccaNova Therapeutics?

Investors on record for SiccaNova Therapeutics include JIC Venture Growth Investments, MPower Partners, Tohoku University Venture Partners, Joyo Capital Partners, 77 Partners. FundedIQ records 6 investors in total.

Where is SiccaNova Therapeutics headquartered?

SiccaNova Therapeutics is based in Tsukuba, Japan.

When was SiccaNova Therapeutics founded?

SiccaNova Therapeutics was founded in 2022.

About FundedIQ's SiccaNova Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SiccaNova Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.